|
1
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
GLOBOCAN 2012 (IARC) Section of Cancer
Information. http://globocan.iarc.fr/Pages/fact_sheets_population.aspxAccessed.
September 15–2014
|
|
3
|
AIRTUM-Italian SocietyCancer Registries. I
numeridel cancro in Italia. 2013.http://www.registri-tumori.it/cmsAccessed.
September 19–2014
|
|
4
|
Capocaccia R, Martina L, Inghelmann R,
Crocetti E, De Lisi V, Falcini F, Guzzinati S, Rosso S, Tagliabue
G, Tumino R, et al: A method to estimate mortality trends when
death certificates are imprecisely coded: An application to
cervical cancer in Italy. Int J Cancer. 124:1200–1205. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Giorgi Rossi P, Camilloni L, Cogo C,
Federici A, Ferroni E, Furnari G, Giordano L, Grazzini G, Iossa A,
Jimenez B, et al: Methods to increase participation in cancer
screening programmes. Epidemiol Prev. 36(1 Suppl 1): S1–S104.
2012.
|
|
6
|
CCM Italy-Centro Controllo malattie,
ministero della Salute. Dieci annidi programmidi screening in
Italia. Roma Zadig ed. 2012.http://www.osservatorionazionalescreening.it/sites/default/files/allegati/Brochure_10anni.pdfAccessed.
September 20–2014
|
|
7
|
ONS 2014. I programmidi screening in
Italia. Rapporto ONS 2014. Roma. Zadig ed. 2014.http://www.osservatorionazionalescreening.it/sites/default/files/allegati/Screening_2014_web.pdfAccessed.
September 02–2014
|
|
8
|
Altobelli E and Lattanzi A: Cervical
carcinoma in the European union: An update ondisease burden,
screening program state of activation, and coverage as of march
2014. Int J Gynecol Cancer. 25:474–483. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
ISTAT. Istituto Nazionale di
Statistica-Italia. http://demo.istat.it/Accessed. October
10–2014
|
|
10
|
Arbyn M, Anttila A, Jordan J, Ronco G,
Schenck U, Segnan N, Wiener H, Herbert A and von Karsa L: European
guidelines for quality assurance in cervical cancer screening.
Second edition-summary document. Ann Oncol. 21:448–458. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wright TC Jr, Cox JT, Massad LS, Twiggs LB
and Wilkinson EJ: ASCCP-Sponsored Consensus Conference: 2001
Consensus guidelines for the management of women with cervical
cytological abnormalities. JAMA. 287:2120–2129. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Berardi R, Nacciarriti D, Tamburrano T,
Carbonari G, Romagnoli E, Duca M, Burattini M, Silva RR, Cellerino
R and Cascinu S: Women's Council of the City of Senigallia, Ancona,
Italy: Compliance with breast and cervical cancer screening
programs in women: Results from a population-based study. Tumori.
99:565–571. 2013.PubMed/NCBI
|
|
13
|
Waller J, Jackowska M, Marlow L and Wardle
J: Exploring age differences in reasons for nonattendance for
cervical screening: A qualitative study. BJOG. 119:26–32. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cox JT, Castle PE, Behrens CM, Sharma A,
Wright TC Jr and Cuzick J: Athena HPV Study Group: Comparison of
cervical cancer screening strategies incorporating different
combinations of cytology, HPV testing, and genotyping for HPV
16/18: Results from the ATHENA HPV study. Am J Obstet Gynecol.
208:184.e1–e184.e11. 2013. View Article : Google Scholar
|
|
15
|
Ronco G, Giorgi-Rossi P, Carozzi F,
Confortini M, Dalla Palma P, Del Mistro A, et al: Efficacy of human
papillomavirus testing for the detection of invasive cervical
cancers and cervical intraepithelial neoplasia: A randomised
controlled trial. Lancet Oncol. 11:249–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rijkaart DC, Berkhof J, Rozendaal L, van
Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J,
Snijders PJ and Meijer CJ: Human papillomavirus testing for the
detection of high-grade cervical intraepithelial neoplasia and
cancer: Final results of the POBASCAM randomised controlled trial.
Lancet Oncol. 13:78–88. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Goldhaber-Fiebert JD, Stout NK, Salomon
JA, Kuntz KM and Goldie SJ: Cost-effectiveness of cervical cancer
screening with human papillomavirus DNA testing and HPV-16,18
vaccination. J Natl Cancer Inst. 100:308–320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giorgi Rossi P, Fortunato C, Barbarino P,
Boveri S, Caroli S, Del Mistro A, Ferro A, Giammaria C, Manfredi M,
Moretto T, et al: Self-sampling to increase participation in
cervical cancer screening: An RCT comparing home mailing,
distribution in pharmacies, and recall letter. Br J Cancer.
112:667–675. 2015. View Article : Google Scholar : PubMed/NCBI
|
